The Roichman Lab studies how diet and the gut microbiome interact to generate bioactive metabolites that shape liver function, metabolism, cancer development, and therapeutic response. We combine in vitro and in vivo models with state-of-the-art HPLC, high-resolution LC–MS, and computational approaches to identify novel metabolites at the diet-microbiome-host axis and define their impact on health and disease.